SpyGlass Pharma CEO Patrick Mooney files Form 3

SpyGlass Pharma, Inc. director and Chief Executive Officer Patrick H. Mooney filed an initial ownership report, showing his beneficial holdings in the company.

Rhea-AI Filing Summary

SpyGlass Pharma, Inc. director and Chief Executive Officer Patrick H. Mooney filed an initial ownership report, showing his beneficial holdings in the company. He directly owns 183,153 shares of common stock and holds several stock options to acquire additional common shares at exercise prices ranging from $0.35 to $7.11, with expiration dates extending to 2035. The options generally vest over four years, with 25% vesting after one year from each grant’s vesting commencement date and the remainder vesting monthly, contingent on his continued service to the company.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Mooney Patrick H.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy)	--	--	--
holding	Stock Option (right to buy)	--	--	--
holding	Stock Option (right to buy)	--	--	--
holding	Stock Option (right to buy)	--	--	--
holding	Stock Option (right to buy)	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 907,626 contracts (Direct); Common Stock — 183,153 shares (Direct)

Footnotes (6)

1. F1. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean July 2, 2021.
2. F2. Of the 1,696,694 shares subject to the option that were originally granted prior to a 5.7329 to 1 reverse stock split, 1,050,000 shares were exercised pre-reverse stock split and prior to the Reporting Person becoming a Section 16 executive officer and director.
3. F3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean October 6, 2023.
4. F4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean December 13, 2024.
5. F5. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 20, 2025.
6. F6. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 30, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SpyGlass Pharma (SGP) disclose in Patrick Mooney’s Form 3?

SpyGlass Pharma reports Patrick H. Mooney’s initial beneficial ownership as director and CEO. He directly holds 183,153 common shares and several stock option grants with various exercise prices and expirations, outlining his equity stake and incentive alignment with the company’s long-term performance.

How many SpyGlass Pharma (SGP) common shares does Patrick Mooney beneficially own?

Patrick H. Mooney beneficially owns 183,153 shares of SpyGlass Pharma common stock directly. This direct equity position is reported alongside his stock option holdings, providing a clear picture of his current ownership at the time of the Form 3 filing on February 5, 2026.

What stock options in SpyGlass Pharma (SGP) does Patrick Mooney hold?

Patrick H. Mooney holds multiple stock options to buy SpyGlass Pharma common shares, including 112,803 shares at $0.35 and 329,784 shares at $7.11. These options have expiration dates between July 2021 grant-related schedules and July 23, 2035, reflecting long-term incentive awards.

How do Patrick Mooney’s SpyGlass Pharma (SGP) options vest?

Each option grant generally vests 25% on the one-year anniversary of its vesting commencement date, then 1/36 of the remaining shares monthly. Vesting continues only while Mooney remains a “Service Provider” under SpyGlass Pharma’s Amended and Restated 2019 Equity Incentive Plan.

What is noted about the SpyGlass Pharma (SGP) reverse stock split in Mooney’s Form 3?

The filing explains one option originally covered 1,696,694 shares before a 5.7329-to-1 reverse stock split. Of those, 1,050,000 shares were exercised before the reverse split and before Patrick Mooney became a Section 16 executive officer and director at SpyGlass Pharma.

What role does Patrick H. Mooney hold at SpyGlass Pharma (SGP) in this Form 3?

Patrick H. Mooney is identified as both a director and the Chief Executive Officer of SpyGlass Pharma. The Form 3 details his status as a reporting person under Section 16 and outlines his direct common stock holdings and stock option positions in the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/05/2026 - 01:00 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mooney Patrick H.

(Last) (First) (Middle)

C/O SPYGLASS PHARMA, INC.

27061 ALISO CREEK RD., SUITE 100

(Street)

ALISO VIEJO CA 92656

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/05/2026

3. Issuer Name and Ticker or Trading Symbol
SpyGlass Pharma, Inc. [ SGP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	183,153	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	07/25/2031	Common Stock	112,803(2)	$0.35	D
Stock Option (right to buy)	(3)	10/05/2033	Common Stock	232,517	$2.18	D
Stock Option (right to buy)	(4)	12/29/2034	Common Stock	105,536	$2.18	D
Stock Option (right to buy)	(5)	04/10/2035	Common Stock	126,986	$2.87	D
Stock Option (right to buy)	(6)	07/23/2035	Common Stock	329,784	$7.11	D

Explanation of Responses:

1. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean July 2, 2021.

2. Of the 1,696,694 shares subject to the option that were originally granted prior to a 5.7329 to 1 reverse stock split, 1,050,000 shares were exercised pre-reverse stock split and prior to the Reporting Person becoming a Section 16 executive officer and director.

3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean October 6, 2023.

4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean December 13, 2024.

5. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 20, 2025.

6. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 30, 2025.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Brian Aukshunas, as Attorney-in-FAct	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.